|
BACH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.256570E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.453000E-01 |
| Normal-vs-Stage2 |
7.299100E-03 |
| Normal-vs-Stage3 |
3.023200E-01 |
| Normal-vs-Stage4 |
1.872980E-01 |
| Stage1-vs-Stage2 |
1.636100E-02 |
| Stage1-vs-Stage3 |
9.667600E-01 |
| Stage1-vs-Stage4 |
6.346800E-01 |
| Stage2-vs-Stage3 |
2.196000E-02 |
| Stage2-vs-Stage4 |
8.989600E-02 |
| Stage3-vs-Stage4 |
6.249200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.409400E-01 |
| Normal-vs-AfricanAmerican |
5.946000E-01 |
| Normal-vs-Asian |
1.910810E-01 |
| Caucasian-vs-AfricanAmerican |
1.307790E-01 |
| Caucasian-vs-Asian |
5.284800E-01 |
| AfricanAmerican-vs-Asian |
9.422100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.163840E-01 |
| Normal-vs-Female |
1.637400E-01 |
| Male-vs-Female |
6.455400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.055400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.804300E-02 |
| Normal-vs-Age(61-80Yrs) |
4.511500E-02 |
| Normal-vs-Age(81-100Yrs) |
7.435000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.177600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.509900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.161000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.232200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.921800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.104600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.961000E-01 |
| Classical-VS-Follicular |
7.23876514285848E-12 |
| Classical-VS-Other |
5.805800E-01 |
| Classical-VS-Normal |
7.601600E-01 |
| Tall-VS-Follicular |
2.40730000000688E-06 |
| Tall-VS-Other |
4.284800E-01 |
| Tall-VS-Normal |
8.296800E-01 |
| Follicular-VS-Other |
7.840000E-02 |
| Follicular-VS-Normal |
2.16699999999737E-05 |
| Other-VS-Normal |
5.632800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.383200E-03 |
| Normal-vs-N1 |
2.863600E-01 |
| N0-vs-N1 |
9.820500E-02 |
|
|
